NASDAQ · Financial Statements
Day One Biopharmaceuticals, Inc. (DAWN) Financial Statements
$21.53
NASDAQ: DAWN
Market Cap $2.22B
Overview Financials Dividend Day One Biopharmaceuticals, Inc. most recently reported annual revenue of $158.0M, net profit of $-107.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $131.0M $158.0M Operating Profit $-73.0M $-147.0M $-206.0M $-217.0M $-128.0M Net Profit $-71.0M $-142.0M $-189.0M $-95.0M $-107.0M EPS $-1.14 $-2.02 $-2.37 $-1.02 $-1.04 Op Margin — — — -165.7% -80.8%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $290.0M $349.0M $376.0M $583.0M $508.0M Total Liabilities $9.0M $17.0M $30.0M $80.0M $67.0M Cash $284.0M $85.0M $231.0M $125.0M $197.0M Borrowings $0 $1.0M $0 $3.0M $3.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-49.0M $-110.0M $-147.0M $-78.0M $-104.0M Investing Cash Flow $-16.0M $-255.0M $125.0M $-233.0M $174.0M Financing Cash Flow $0 $4.0M $0 $25.0M $0 Net Cash Flow $241.0M $-199.0M $146.0M $-106.0M $72.0M Free Cash Flow $-57.0M $-110.0M $-150.0M $-80.0M $-104.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.40 EV / EBITDA -19.24 FCF Yield -4.84% Quick Ratio 7.91 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock